Carson Advisory’s Gilead Sciences GILD Stock Holding History

Carson Advisory’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$553K	Hold	3,968	–	–	0.29%	81
2025 Q4	$487K	Buy	3,968 +40	+1%	+$4.86K	0.25%	86
2025 Q3	$436K	Sell	3,928 -200	-5%	-$22.7K	0.24%	87
2025 Q2	$458K	Sell	4,128 -500	-11%	-$53.2K	0.29%	77
2025 Q1	$519K	Hold	4,628	–	–	0.35%	69
2024 Q4	$427K	Sell	4,628 -300	-6%	-$27K	0.3%	77
2024 Q3	$413K	Hold	4,928	–	–	0.26%	97
2024 Q2	$338K	Hold	4,928	–	–	0.24%	104
2024 Q1	$361K	Hold	4,928	–	–	0.25%	101
2023 Q4	$399K	Buy	4,928 +29	+0.6%	+$2.26K	0.31%	92
2023 Q3	$367K	Hold	4,899	–	–	0.32%	93
2023 Q2	$378K	Sell	4,899 -400	-8%	-$31.9K	0.32%	89
2023 Q1	$440K	Sell	5,299 -700	-12%	-$58K	0.39%	77
2022 Q4	$515K	Buy	+5,999	New	+$475K	0.49%	57

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Carson Advisory's GILD Position: Q1 2026 in Review

Carson Advisory held its Gilead Sciences (GILD) position steady in Q1 2026 at 3,968 shares worth $553K. The position accounts for 0.29% of the portfolio, ranked #81.

Carson Advisory first reported a position in GILD in Q4 2022 and has held it in 14 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Carson Advisory held 3,968 shares of Gilead Sciences worth $553K as of Q1 2026.
Carson Advisory left its Gilead Sciences share count unchanged in Q1 2026.
Gilead Sciences made up 0.29% of Carson Advisory's portfolio in Q1 2026, its #81 holding.
Carson Advisory first reported a position in Gilead Sciences in Q4 2022 and has held it in 14 quarters since.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Carson Advisory's 13F filing for Q1 2026, filed 7 May 2026.